"During my interviews, I realized that Fish is a special place," says Esin Gumustekin, who chose to spend her 1L summer at Fish because of our reputation as the leading IP firm. "Not only could I work on pharma and biotech cases, but do so with the best IP lawyers in the country." We're now accepting applications for our 2025 summer program. Learn more: https://hubs.li/Q02ZB1tc0 #FishRichardson
关于我们
As the leading intellectual property law firm, we help innovators change the world through our unmatched litigation, prosecution, and post-grant experience across venues and prosecution needs. We touch more PTAB cases, IP appeals, and utility patents than anyone else, and no national firm handles more District Court patent cases. Many of our 425+ attorneys and technology specialists are also scientists who are as comfortable in a lab or cleanroom as a courtroom or patent office. Visionaries across eras have trusted us to protect their IP since 1878, and we’re ready to help build your IP strategy today with tomorrow in mind.?
- 网站
-
https://www.fr.com
Fish & Richardson P.C.的外部链接
- 所属行业
- 律师事务所
- 规模
- 501-1,000 人
- 总部
- Boston，MA
- 类型
- 私人持股
- 领域
- law、legal、intellectual property、patent、litigation、trademark和post-grant
地点
Fish & Richardson P.C.员工
动态
-
On December 17, please join Principals Benjamin Elacqua, Scott M. Flanz, and Christopher Green for an overview of standard essential patents (SEPs). Our hosts will cover emerging standards and key associated member obligations, critical jurisdictions for standards litigation worldwide, best practices for SEP assertion and defense, and more. https://hubs.li/Q02ZyGQr0 #FishRichardson
-
-
In Nested Bean v. Big Beings, Director Vidal considered how multiple dependent claims should be addressed in PTAB proceedings. Find out how she ruled in this Director Review Spotlight by Principals Hyun Jin "HJ" In and Jeremy Monaldo. https://hubs.li/Q02ZxF0j0 #FishRichardson
-
As the Trump administration prepares for its second term, questions arise about the future of drug patents and the biopharmaceutical industry. Principal Megan Chacon offers her insights in an interview with Life Science Leader. She discusses potential changes at the USPTO, policy shifts, and counsels industry leaders on the importance of patience and communication during this transitional period. Read the full article: https://hubs.li/Q02Zsr6D0 #FishRichardson
Principal Megan Chacon Explores Changes to Biopharma Patent Landscape During Second Trump Administration
fr.com
-
The USPTO has finalized its proposed patent fee adjustments, which will go into effect on January 19, 2025. Find out what's changing in our latest legal alert. https://hubs.li/Q02Zq15S0 #FishRichardson
New USPTO Patent Fees Go Into Effect January 19, 2025
fr.com
-
On December 11, Attorneys David Hoffman and Michael Headley will present the San Francisco Bay Area Chapter of the Association of Corporate Counsel webinar “IP Challenges and Strategies for Startups," a discussion of how startups can build and protect their IP. https://hubs.li/Q02YV4Vt0 #FishRichardson
ACC San Francisco Bay Area Program: IP Challenges and Strategies for Startups
fr.com
-
Of Counsel Giordana Mahn was recently invited to share her insights on the intersection of women's health and IP at the IDEA Annual Symposium: Modern Intellectual Property Scholarship. Her presentation was titled "Outlook and Opportunities for Innovating in Women's Health Technology." #FishRichardson
-
-
On December 9, Principal Indranil Sarkar will present “Blockchain Patenting Strategy in Relation to Business Strategy” at Practicing Law Institute Patenting Blockchain and Distributed Ledger Technologies. https://hubs.li/Q02YYjw60 #FishRichardson
Practicing Law Institute Patenting Blockchain and Distributed Ledger Technologies 2024
fr.com
-
Principal Olivia T. Nguyen will present “Emerging Defense Tactics: Prosecution Laches, Unclean Hands, and Inequitable Conduct” at the 25th annual Berkeley-Stanford Advanced Patent Law Institute on December 6. https://hubs.li/Q02YYhF20 #FishRichardson
Berkeley-Stanford Advanced Patent Law Institute 2024
fr.com
-
On December 11, please join Principals Greg Booker and Karrie Wheatley JD, PhD for a webinar discussion of how the Federal Trade Commission's recent interest in the Orange Book could affect branded pharmaceutical companies. https://hubs.li/Q02YYn1V0 #FishRichardson
The FTC and the Orange Book: Considerations for Patent Owners
fr.com